Apar Ganti, MD
University of Nebraska
3
3
1
N/A
0
11
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Vincent Chung
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
David R. Spigel, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Worked with same sponsors:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Glenn Lesser, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Worked with same sponsors:
Soo Chin Lee
National University Hospital, Singapore
Shared therapeutic areas:
Arun Rajan, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer
All 3 trials loaded